Effectiveness of a Wilms tumour treatment guideline adapted to local circumstances in sub-Saharan Africa: A report from Wilms Africa Phase II-CANCaRe Africa.
Diriba Fufa HordofaCecilia MdokaMulugeta AyalewHarriet KhofiEmmanuel AmankwahNester ChokwendaEsubalew MezgebuAnnelies M C Mavinkurve-GroothuisSteve KamizaBeatrice Chikaphonya-PhiriMulugeta WassieBarnabas AtwiineMushabe BranchardMaite GorosteguiJeannette ParkesEvaristar KudowaBernice EkluBrian JatorLorna Awo RennerEric BorgsteinElizabeth MolyneuxFrancine KouyaKathy Pritchard-JonesVivian PaintsilInam ChitsikeGeorge ChagalukaTrijn IsraelsPublished in: Pediatric blood & cancer (2024)
Patients continue to present late with advanced WT in sub-Saharan Africa, and their survival is below the 60% GICC target. Prevention of treatment abandonment and treatment-related mortality remain important. Earlier diagnosis and access to radiotherapy are expected to decrease disease-related mortality.